Get the Stockscreener App
42.31
0.66%
-0.28
After Hours:
42.38
0.07
+0.17%
Eton Pharmaceuticals Inc stock is traded at $42.31, with a volume of 365.37K.
It is down -0.66% in the last 24 hours and up +18.52% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$42.59
Open:
$42.73
24h Volume:
365.37K
Relative Volume:
0.84
Market Cap:
$1.16B
Revenue:
$86.93M
Net Income/Loss:
$-1.48M
P/E Ratio:
-596.76
EPS:
-0.0709
Net Cash Flow:
$431.00K
1W Performance:
+3.02%
1M Performance:
+18.52%
6M Performance:
+181.32%
1Y Performance:
+174.74%
1-Day Range:
$42.06
$43.84
1-Week Range:
$40.86
$44.91
52-Week Range:
$13.78
$44.91
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
42.31 | 1.17B | 86.93M | -1.48M | 431.00K | -0.0709 |
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Eton Pharmaceuticals Inc (ETON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ETON|Eton Pharmaceuticals Inc|Price:42.590|Chg%:-1.550 - TradingKey
The Technical Signals Behind (ETON) That Institutions Follow - Stock Traders Daily
Eton Pharmaceuticals (ETON) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
Eton Pharmaceuticals stock hits all-time high at 44.0 USD - Investing.com UK
Eton Pharmaceuticals stock hits all-time high at 44.0 USD By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals Inc. (ETON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Eton Pharmaceuticals: Here Is How I Handle My Position With The Stock Skyrocketing (Downgrade) - Seeking Alpha
Eton Pharmaceuticals (ETON) moves 13.8% higher: Will this strength last? - MSN
Eton Pharmaceuticals (ETON) Gains On Rare Disease Momentum, Is It Still Undervalued? - Sahm
Eton Pharmaceuticals Inc (ETON) Shares Fall 3.1% -- What GF Scor - GuruFocus
Eton Pharmaceuticals (ETON) Moves 13.8% Higher: Will This Strength Last? - Yahoo Finance
Eton Pharmaceuticals (ETON) Surges 13.8%: Breaking Above Key Resistance LevelsQuality ETF - dars.gov.et
ETON Surges As Canaccord Sets Aggressive $60 Price Target - StocksToTrade
ETON Jumps As Canaccord’s $60 Price Target Signals Growth - timothysykes.com
Opaleye management sells $1.06m in Eton Pharmaceuticals stock By Investing.com - Investing.com Australia
Form 4 Eton Pharmaceuticals Inc For: 17 July By Investing.com - Investing.com India
Opaleye management sells $1.06m in Eton Pharmaceuticals stock - Investing.com
Opaleye Management sells 28315 Eton Pharmaceuticals (ETON) shares on July 14 - Stock Titan
ETON Stock Pops As Canaccord Genuity Targets $60 - timothysykes.com
ETON PHARMACEUTICALS INC : CANACCORD GENUITY INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $60 - Bitget
Form 4 Eton Pharmaceuticals Inc For: 16 July By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals stock hits all-time high at 38.76 USD By Investing.com - Investing.com South Africa
Eton Pharmaceuticals stock hits all-time high at 38.76 USD - Investing.com UK
Opaleye management sells $1.06m Eton Pharmaceuticals stock By Investing.com - Investing.com Canada
Opaleye management sells $1.06m Eton Pharmaceuticals stock - Investing.com
Eton Pharmaceuticals (ETON) holder Opaleye reports July stock sales - Stock Titan
Form 4 Eton Pharmaceuticals Inc For: 14 July By Investing.com - Investing.com Canada
Eton Pharmaceuticals (ETON) CEO exercises options and RSUs, increasing stake - Stock Titan
Eton Pharmaceuticals (NASDAQ: ETON) CBO converts 10,000 RSUs into common shares - Stock Titan
Eton Pharmaceuticals (ETON) Edges Higher as Stock Tests Key Resistance LevelsDark Pool Volume - dars.gov.et
Major Investor Makes Bold Move in Eton Pharmaceuticals - TipRanks
Opaleye management sells $4.77m Eton Pharmaceuticals (ETON) stock By Investing.com - Investing.com Nigeria
Form 4 Eton Pharmaceuticals Inc For: 7 July By Investing.com - Investing.com Nigeria
Opaleye management sells $4.77m Eton Pharmaceuticals (ETON) stock - Investing.com
Form 4 Eton Pharmaceuticals Inc For: 7 July - Investing.com India
Opaleye trims Eton Pharmaceuticals (ETON) stake with open-market sales - Stock Titan
Eton Pharmaceuticals highlights its niche rare-disease focus as a specialty drug developer - Ad-hoc-news.de
Eton Pharmaceuticals stock hits all-time high at 38.6 USD By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals stock hits all-time high at 38.6 USD - Investing.com
Frontier tech research, news & data - MLQ.ai
Precision Trading with Eton Pharmaceuticals Inc. (ETON) Risk Zones - Stock Traders Daily
Enterprise value to revenue forward of Eton Pharmaceuticals, Inc. – NASDAQ:ETON - TradingView
Form 4 Eton Pharmaceuticals Inc For: 30 June By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals (ETON) CBO awarded 10,000 restricted stock units - Stock Titan
Eton Pharmaceuticals stock hits all-time high at 36.97 USD - Investing.com
Eton Pharmaceuticals stock hits all-time high at 36.97 USD By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.30%
2.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):